Idexx Laboratories (IDXX) Recently Broke Out Above the 20-Day Moving Average
Werte in diesem Artikel
From a technical perspective, Idexx Laboratories (IDXX) is looking like an interesting pick, as it just reached a key level of support. IDXX recently overtook the 20-day moving average, and this suggests a short-term bullish trend.A well-liked tool among traders, the 20-day simple moving average offers a look back at a stock's price over a 20-day period. This is very beneficial to short-term traders, as it smooths out short-term price trends and gives more trend reversal signals than longer-term moving averages.Like other SMAs, if a stock's price is moving above the 20-day, the trend is considered positive. When the price falls below the moving average, it can signal a downward trend.IDXX could be on the verge of another rally after moving 21.1% higher over the last four weeks. Plus, the company is currently a Zacks Rank #2 (Buy) stock.The bullish case solidifies once investors consider IDXX's positive earnings estimate revisions. No estimate has gone lower in the past two months for the current fiscal year, compared to 7 higher, while the consensus estimate has increased too.Investors should think about putting IDXX on their watchlist given the ultra-important technical indicator and positive move in earnings estimate revisions.Zacks Names #1 Semiconductor StockThis under-the-radar company specializes in semiconductor products that titans like NVIDIA don't build. It's uniquely positioned to take advantage of the next growth stage of this market. And it's just beginning to enter the spotlight, which is exactly where you want to be.With strong earnings growth and an expanding customer base, it's positioned to feed the rampant demand for Artificial Intelligence, Machine Learning, and Internet of Things. Global semiconductor manufacturing is projected to explode from $452 billion in 2021 to $971 billion by 2028.See This Stock Now for Free >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report IDEXX Laboratories, Inc. (IDXX): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks
Übrigens: IDEXX Laboratories und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und Neukunden-Bonus sichern!
Ausgewählte Hebelprodukte auf Broke Out
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Broke Out
Der Hebel muss zwischen 2 und 20 liegen
Name | Hebel | KO | Emittent |
---|
Name | Hebel | KO | Emittent |
---|
Quelle: Zacks
Nachrichten zu IDEXX Laboratories
Analysen zu IDEXX Laboratories
Datum | Rating | Analyst | |
---|---|---|---|
07.05.2018 | IDEXX Laboratories Buy | Stifel, Nicolaus & Co., Inc. | |
03.02.2017 | IDEXX Laboratories Sell | Feltl & Co. | |
20.07.2016 | IDEXX Laboratories Buy | Canaccord Adams | |
19.04.2016 | IDEXX Laboratories Buy | Canaccord Adams | |
21.03.2016 | IDEXX Laboratories Buy | Stifel, Nicolaus & Co., Inc. |
Datum | Rating | Analyst | |
---|---|---|---|
07.05.2018 | IDEXX Laboratories Buy | Stifel, Nicolaus & Co., Inc. | |
20.07.2016 | IDEXX Laboratories Buy | Canaccord Adams | |
19.04.2016 | IDEXX Laboratories Buy | Canaccord Adams | |
21.03.2016 | IDEXX Laboratories Buy | Stifel, Nicolaus & Co., Inc. | |
29.10.2015 | IDEXX Laboratories Buy | Stifel, Nicolaus & Co., Inc. |
Datum | Rating | Analyst | |
---|---|---|---|
08.11.2012 | IDEXX Laboratories hold | Stifel, Nicolaus & Co., Inc. | |
12.04.2005 | Update Idexx Laboratories: Market Perform | William Blair |
Datum | Rating | Analyst | |
---|---|---|---|
03.02.2017 | IDEXX Laboratories Sell | Feltl & Co. |
Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für IDEXX Laboratories nach folgenden Kriterien zu filtern.
Alle: Alle Empfehlungen